Geron abandons stem cell therapy as treatment for paralysis
16 November 2011
Professor John Martin (Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Cardiovascular Medicine) comments on the announcement by biotech company Geron that it will abandon the first ever stem cell trial to treat paralysis.